227 related articles for article (PubMed ID: 18549507)
1. Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy.
Bhuvaneswari R; Gan YY; Lucky SS; Chin WW; Ali SM; Soo KC; Olivo M
Mol Cancer; 2008 Jun; 7():56. PubMed ID: 18549507
[TBL] [Abstract][Full Text] [Related]
2. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
[TBL] [Abstract][Full Text] [Related]
3. Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins.
Bhuvaneswari R; Yuen GY; Chee SK; Olivo M
Photochem Photobiol Sci; 2007 Dec; 6(12):1275-83. PubMed ID: 18046482
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model.
Bhuvaneswari R; Yuen GY; Chee SK; Olivo M
Lasers Surg Med; 2011 Sep; 43(7):651-62. PubMed ID: 22057493
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy.
Bhuvaneswari R; Thong PS; Gan YY; Soo KC; Olivo M
J Biomed Opt; 2010; 15(1):011114. PubMed ID: 20210440
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
Chin W; Lau W; Cheng C; Olivo M
Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863
[TBL] [Abstract][Full Text] [Related]
7. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
Thong PS; Watt F; Ren MQ; Tan PH; Soo KC; Olivo M
J Photochem Photobiol B; 2006 Jan; 82(1):1-8. PubMed ID: 16203156
[TBL] [Abstract][Full Text] [Related]
8. Novel Insights into the Effect of Hyperforin and Photodynamic Therapy with Hypericin on Chosen Angiogenic Factors in Colorectal Micro-Tumors Created on Chorioallantoic Membrane.
Majerník M; Jendželovský R; Babinčák M; Košuth J; Ševc J; Tonelli Gombalová Z; Jendželovská Z; Buríková M; Fedoročko P
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248208
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma.
Yee KK; Soo KC; Olivo M
Int J Mol Med; 2005 Dec; 16(6):993-1002. PubMed ID: 16273277
[TBL] [Abstract][Full Text] [Related]
10. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
Buytaert E; Matroule JY; Durinck S; Close P; Kocanova S; Vandenheede JR; de Witte PA; Piette J; Agostinis P
Oncogene; 2008 Mar; 27(13):1916-29. PubMed ID: 17952126
[TBL] [Abstract][Full Text] [Related]
11. Antivascular tumor eradication by hypericin-mediated photodynamic therapy.
Chen B; Roskams T; de Witte PA
Photochem Photobiol; 2002 Nov; 76(5):509-13. PubMed ID: 12462645
[TBL] [Abstract][Full Text] [Related]
12. Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases.
Barathan M; Mariappan V; Shankar EM; Abdullah BJ; Goh KL; Vadivelu J
Cell Death Dis; 2013 Jun; 4(6):e697. PubMed ID: 23807226
[TBL] [Abstract][Full Text] [Related]
13. Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells.
Ali SM; Olivo M
Int J Oncol; 2002 Sep; 21(3):531-40. PubMed ID: 12168096
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model.
Chen B; Roskams T; Xu Y; Agostinis P; de Witte PA
Int J Cancer; 2002 Mar; 98(2):284-90. PubMed ID: 11857421
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic treatment (Bevacizumab) improves the responsiveness of photodynamic therapy in colorectal cancer.
Peng CL; Lin HC; Chiang WL; Shih YH; Chiang PF; Luo TY; Cheng CC; Shieh MJ
Photodiagnosis Photodyn Ther; 2018 Sep; 23():111-118. PubMed ID: 29894822
[TBL] [Abstract][Full Text] [Related]
16. Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.
Miyake M; Fujimoto K; Anai S; Ohnishi S; Kuwada M; Nakai Y; Inoue T; Matsumura Y; Tomioka A; Ikeda T; Tanaka N; Hirao Y
Oncol Rep; 2011 Mar; 25(3):653-60. PubMed ID: 21206978
[TBL] [Abstract][Full Text] [Related]
17. Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription.
Xu L; Zhang X; Cheng W; Wang Y; Yi K; Wang Z; Zhang Y; Shao L; Zhao T
Retrovirology; 2019 Feb; 16(1):5. PubMed ID: 30782173
[TBL] [Abstract][Full Text] [Related]
18. Hypericin-mediated photodynamic therapy inhibits growth of colorectal cancer cells via inducing S phase cell cycle arrest and apoptosis.
Hu J; Song J; Tang Z; Wei S; Chen L; Zhou R
Eur J Pharmacol; 2021 Jun; 900():174071. PubMed ID: 33811836
[TBL] [Abstract][Full Text] [Related]
19. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
[TBL] [Abstract][Full Text] [Related]
20. Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer.
Du HY; Olivo M; Tan BK; Bay BH
Int J Oncol; 2003 Nov; 23(5):1401-5. PubMed ID: 14532982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]